Howard W. Robin
2020
In 2020, Howard W. Robin earned a total compensation of $11.2M as President and Chief Executive Officer at Nektar Therapeutics, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,092,000 |
|---|---|
| Option Awards | $4,004,108 |
| Salary | $1,053,400 |
| Stock Awards | $4,996,266 |
| Other | $95,775 |
| Total | $11,241,549 |
Robin received $5M in stock awards, accounting for 44% of the total pay in 2020.
Robin also received $1.1M in non-equity incentive plan, $4M in option awards, $1.1M in salary and $95.8K in other compensation.
Rankings
In 2020, Howard W. Robin's compensation ranked 694th out of 13,090 executives tracked by ExecPay. In other words, Robin earned more than 94.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 694 out of 13,090 | 95th |
Division Manufacturing | 241 out of 5,617 | 96th |
Major group Chemicals And Allied Products | 77 out of 2,248 | 97th |
Industry group Drugs | 66 out of 1,948 | 97th |
Industry Pharmaceutical Preparations | 49 out of 1,453 | 97th |
Source: SEC filing on April 30, 2021.
Robin's colleagues
We found four more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2020.